PROGRESSIVE DISEASE
Clinical trials for PROGRESSIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in battle against Tough-to-Treat gynecologic cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, niraparib (a pill) and copanlisib (an IV infusion), for women whose ovarian, endometrial, or related cancers have returned after prior treatment. The main goals are to find the safest dose of this combination and to le…
Matched conditions: PROGRESSIVE DISEASE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New triple attack on tough colon cancer shows promise
Disease control OngoingThis study is testing a combination of three drugs (encorafenib, cetuximab, and nivolumab) for people with advanced colorectal cancer that has a specific BRAF gene mutation and has spread or cannot be removed by surgery. The goal is to find the safest dose and see if the three dr…
Matched conditions: PROGRESSIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC